Finzati - Logo
XTLB logo

XTL Biopharmaceuticals Ltd.

XTLBBiotechnology
$2.53
+0.03 (+1.20%)
Current price
EarningsLatest report: Dec 31, 2024
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$275,062.5
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Weak liquidity · 0.61Weak profitability
Financial data as of: Dec 31, 2024, 12:00 AM UTCLast earnings update: Jan 1, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.53
Change1.20%
Shares Out110.03K
Market Cap$275.06K
Enterprise Value$-729.94K
52W Range2.01 - 10.28
Beta0.56
P/E-0.27
P/S0.61
P/B0.05
EV/Sales-1.62
EV/EBITDA0.92

Investment DNA

How strong this company looks for long-term investors

43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score
Manageable debt level · 0.03Weak liquidity · 0.61Weak profitability

Analyst view

Analyst sentiment and price target

XTLB
Analyst sentiment
Based on 2 analyst votes · 2026-09-04
100/100
Bullish
Bullish
2
Hold
0
Bearish
0

Company Overview

IPO: 9/1/2005
Industry: Biotechnology
P/B i: 0.05
Debt / Equity i: 0.03
Operating Margin: -481.60%
Net Margin: -227.72%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.03
Current Ratio: 0.61
Quick Ratio: 0.61
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

6 high-volume insider sells detected
Segal Niv
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/23/2026
Type
OTHER
Hillel Fain Osnat
Transaction: 03/18/2026
OTHER
Change
+1,000,000
Price
$0.01
Filing
03/23/2026
Type
OTHER
EDELMAN JOSEPH
Transaction: 11/19/2008
SELL
Change
-9,600,000
Price
$0.15
Filing
12/03/2008
Type
SELL